DRW Holdings »

Taysha Gene Therapies shares owned by DRW Holdings

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by DRW Holdings from 13F filings

Historical chart of DRW Holdings investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by DRW Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by DRW Holdings

Quarter filed Position value Share count Share price at filing
2024-03-31 $51k 18k 2.87

More positions owned by DRW Holdings

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Spdr Gold Tr Gold Shs Call Option (GLD)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Grayscale Ethereum Com Unt (ETHE)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation Call Option (MSFT)
Oracle Corporation Call Option (ORCL)
Amazon Call Option (AMZN)
Apple Call Option (AAPL)
Tesla Motors Call Option (TSLA)
Ishares Tr Msci India Etf (INDA)
Facebook Inc cl a Call Option (META)
Alphabet Inc Class A cs Call Option (GOOGL)
Marvell Technology Put Option (MRVL)
Pdd Holdings Sponsored Ads Call Option (PDD)

View all positions for DRW Holdings

Top funds holding Taysha Gene Therapies

FMR
venBio Select Advisor
Rtw Investments
BlackRock
RA Capital Management
VR Adviser
Morgan Stanley
Vanguard Group
Octagon Capital Advisors
Artal Group
Baker Bros. Advisors
Tybourne Capital Management
Longwood Capital Partners
State Street Corporation
Jpmorgan Chase & Co

View all funds holding Taysha Gene Therapies